Centro Studi GISED


Go to content
Change language  EN IT

Systematic review of studies quality on COVID-19 risks in clinical subgroups

What we do

This is a systematic review of the quality of published studies concerning the risks of COVID-19 in potentially high-risk clinical subgroups, such as patients on biological drug therapy, organ transplant recipients and patients on immunosuppressive therapy.

Back to research project


Last update oct 4 2021  -  Centro Studi GISED  P.I. 02274270988 | Terms of use    Privacy    Credits

Back to content | Back to main menu
Facebook Twitter LinkedIn Email